The FDA is waiting to make a decision on COVID-19 vaccines for children under five years old because it is still being studied.
There may be a need for a third dose.
When will it be approved?
A decision about a COVID-19 vaccine for children starting at six months old will probably be made around mid-April. It was previously thought that the vaccine would be available for distribution as early as February 21. Click here for more details.
The CDC announced that regulators will be waiting for the results of an ongoing study. The study is looking into the impacts of a third dose of the vaccine for kids under five years old.
Why wasn’t it approved?
The approval has been delayed because the two-dose vaccine regime didn’t produce a large enough immune response.
The FDA decided to wait rather than ‘fast-track’ approval because the third dose of the vaccine could potentially make it more effective.
Initially, the goal was to get vaccinations out as soon as possible and consider a third dose later.
Pfizer has retained some urgency to produce this vaccine, as they want children in this age group to be protected against COVID-19.